Drug Approval | June 13, 2026
UK approves Wegovy pill in major shift in obesity treatment options
Approval is based on results from the phase 3 OASIS 4 clinical trial
Approval is based on results from the phase 3 OASIS 4 clinical trial
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
